Global Lung Stent Market, By Product Type (Tracheobronchial Stents, Esophageal Stents, Pulmonary Artery Stents, Lobar Bronchus Stents, Others), By Material (Metal Lung Stents, Silicone Lung Stents, Hybrid Lung Stents and Others), By Type (Self-expandable Stents and Balloon- expandable Stents), By End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
The lung stent market has been witnessing steady growth over the past few years, mainly due to the increasing prevalence of chronic respiratory diseases globally. Lung stents are small mesh tubes inserted into the airways of the lungs through minimally invasive procedures to relieve blockages. They play a vital role in improving breathing by keeping constricted or collapsed airways open. Growing geriatric populations who are more prone to chronic lung disorders (including lung cancer, chronic obstructive pulmonary disease (COPD), congenital malformations, and injuries) combined with rising air pollution levels in both developed and developing nations have been augmenting the demand for lung stents. However, the risk of complications associated with lung stents and the availability of alternative treatment options may hamper market expansion to some extent.
Market Dynamics:
The global lung stent market is driven by the growing geriatric population susceptible to chronic lung diseases, increasing pollution levels leading to higher respiratory infections and disorders, and the rising prevalence of lung cancer. According to the World Health Organization, COPD affected over 65 million people globally in 2021 and caused over 3 million deaths. Additionally, technological advances facilitating minimally invasive stent placement through advanced delivery systems and accurate placement are further broadening the market potential. However, high costs associated with lung stenting procedures and product development by manufacturers, as well as post-procedure complications like stent migration, are some of the major factors expected to hinder market growth. Meanwhile, ongoing research and development focusing on bioabsorbable stents and 3D-printed customized stents offer lucrative opportunities for lung stent providers.
Key features of the study:
This report provides an in-depth analysis of the global lung stent market, and provides market size (US$ Mn) and Compound Annual Growth Rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global lung stent market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Boston Scientific, Cook Medical, Medtronic, Taewoong Medical, Hospitech, Bess, Endo-Flex, Efer Endoscopy, W. L. Gore & Associates, BD, Edwards Lifesciences, Healthy Medical Corporation, Pulmonx Corporation, Meril Life Sciences Pvt. Ltd and C. R. Bard Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global lung stent market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung stent market